Prostaglandin-mediated inhibition of the vasoconstrictor responses of the isolated perfused art splenic vasculature to adrenergic stimuli.
D000818:Animals; D005260:Female; D005730:Ganglionic Blockers / Q000494:pharmacology; D008297:Male; D009638:Norepinephrine / Q000494:pharmacology; D010477:Perfusion; D011457:Prostaglandins D / Q000494:pharmacology; D011458:Prostaglandins E / Q000494:pharmacology*; D011460:Prostaglandins F / Q000494:pharmacology; D051381:Rats; D013154:Spleen / Q000098:blood supply*; D013157:Splenic Artery / Q000294:innervation; D013565:Sympatholytics / Q000494:pharmacology; D013566:Sympathomimetics / Q000494:pharmacology*; D013929:Thromboxane B2 / Q000494:pharmacology; D014661:Vasoconstriction / Q000187:drug effects*
D005730:Ganglionic Blockers; D011457:Prostaglandins D; D011458:Prostaglandins E; D011460:Prostaglandins F; D013565:Sympatholytics; D013566:Sympathomimetics; D013929:Thromboxane B2; D009638:Norepinephrine